SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-07-016818
Filing Date
2007-11-08
Accepted
2007-11-08 15:17:07
Documents
9
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c21347e10vq.htm 10-Q 256263
2 FIRST AMENDMENT TO SALES AND MARKETING AGREEMENT c21347exv10w2.htm EX-10.2 6716
3 SIXTH AMENDMENT TO OEM AGREEMENT c21347exv10w3.htm EX-10.3 7421
4 AMENDMENT TO CREDIT AGREEMENT c21347exv10w6.htm EX-10.6 54731
5 NOTE ISSUED IN CONNECTION WITH THE AMENDMENT TO CREDIT AGREEMENT c21347exv10w7.htm EX-10.7 6931
6 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) c21347exv31w1.htm EX-31.1 5891
7 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) c21347exv31w2.htm EX-31.2 5894
8 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 c21347exv32w1.htm EX-32.1 2645
9 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 c21347exv32w2.htm EX-32.2 2936
  Complete submission text file 0000950137-07-016818.txt   350811
Mailing Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 071225431
SIC: 2834 Pharmaceutical Preparations